LDB
ABBV icon

Lee, Danner & Bass’s AbbVie ABBV Stock Holding History

Lee, Danner & Bass’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.24M Sell
20,843
-97
-0.5% -$20.9K 0.3% 71
2026
Q1 		$4.55M Buy
20,940
+80
+0.4% +$17.7K 0.29% 74
2025
Q4 		$4.77M Buy
20,860
+1,574
+8% +$359K 0.34% 65
2025
Q3 		$4.47M Sell
19,286
-280
-1% -$57K 0.32% 69
2025
Q2 		$3.63M Sell
19,566
-127
-0.6% -$23.6K 0.28% 79
2025
Q1 		$4.13M Buy
19,693
+136
+0.7% +$26.4K 0.33% 68
2024
Q4 		$3.48M Buy
19,557
+2,164
+12% +$398K 0.28% 76
2024
Q3 		$3.44M Sell
17,393
-411
-2% -$76.7K 0.24% 83
2024
Q2 		$3.05M Buy
+17,804
New +$2.95M 0.24% 88
2023
Q4 		$2.77M Sell
17,864
-715
-4% -$104K 0.24% 88
2023
Q3 		$2.77M Buy
18,579
+660
+4% +$96.9K 0.25% 85
2023
Q2 		$2.41M Sell
17,919
-567
-3% -$83.1K 0.21% 88
2023
Q1 		$2.95M Hold
18,486
– – 0.27% 80
2022
Q4 		$2.99M Buy
18,486
+533
+3% +$81.7K 0.28% 78
2022
Q3 		$2.41M Buy
17,953
+60
+0.3% +$8.61K 0.25% 82
2022
Q2 		$2.74M Sell
17,893
-56
-0.3% -$8.56K 0.28% 76
2022
Q1 		$2.91M Sell
17,949
-114
-0.6% -$16.6K 0.25% 83
2021
Q4 		$2.45M Hold
18,063
– – 0.21% 92
2021
Q3 		$1.95M Buy
18,063
+1,805
+11% +$206K 0.18% 95
2021
Q2 		$1.83M Hold
16,258
– – 0.17% 99
2021
Q1 		$1.76M Buy
16,258
+40
+0.2% +$4.28K 0.17% 99
2020
Q4 		$1.74M Buy
16,218
+150
+0.9% +$14.4K 0.19% 93
2020
Q3 		$1.41M Buy
16,068
+3,870
+32% +$364K 0.17% 93
2020
Q2 		$1.2M Sell
12,198
-439
-3% -$38.7K 0.15% 99
2020
Q1 		$963K Sell
12,637
-440
-3% -$37.5K 0.14% 99
2019
Q4 		$1.16M Sell
13,077
-88
-0.7% -$7.31K 0.12% 105
2019
Q3 		$997K Sell
13,165
-385
-3% -$26.4K 0.11% 107
2019
Q2 		$985K Buy
13,550
+200
+1% +$15.7K 0.1% 110
2019
Q1 		$1.08M Sell
13,350
-336
-2% -$27.5K 0.12% 104
2018
Q4 		$1.26M Hold
13,686
– – 0.15% 98
2018
Q3 		$1.29M Buy
13,686
+305
+2% +$28.9K 0.13% 106
2018
Q2 		$1.24M Buy
13,381
+765
+6% +$74.7K 0.13% 106
2018
Q1 		$1.19M Sell
12,616
-318
-2% -$34.9K 0.12% 109
2017
Q4 		$1.25M Sell
12,934
-728
-5% -$68.6K 0.13% 107
2017
Q3 		$1.21M Sell
13,662
-1,222
-8% -$93K 0.13% 104
2017
Q2 		$1.08M Sell
14,884
-118
-0.8% -$7.93K 0.12% 106
2017
Q1 		$978K Buy
15,002
+185
+1% +$11.6K 0.11% 106
2016
Q4 		$928K Buy
14,817
+636
+4% +$38.8K 0.11% 105
2016
Q3 		$894K Sell
14,181
-95
-0.7% -$6.15K 0.11% 105
2016
Q2 		$884K Buy
14,276
+400
+3% +$24.4K 0.11% 105
2016
Q1 		$845K Buy
13,876
+366
+3% +$20.4K 0.1% 107
2015
Q4 		$800K Buy
13,510
+850
+7% +$49K 0.1% 109
2015
Q3 		$689K Buy
12,660
+1,700
+16% +$111K 0.09% 114
2015
Q2 		$736K Buy
10,960
+1,504
+16% +$98.2K 0.09% 113
2015
Q1 		$554K Buy
9,456
+975
+11% +$58.9K 0.07% 117
2014
Q4 		$555K Sell
8,481
-937
-10% -$59.1K 0.07% 117
2014
Q3 		$544K Hold
9,418
– – 0.07% 116
2014
Q2 		$532K Hold
9,418
– – 0.06% 112
2014
Q1 		$484K Buy
9,418
+845
+10% +$42.7K 0.06% 113
2013
Q4 		$453K Buy
8,573
+800
+10% +$39.3K 0.06% 112
2013
Q3 		$348K Buy
7,773
+200
+3% +$8.87K 0.05% 124
2013
Q2 		$313K Buy
+7,573
New +$331K 0.05% 125

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Lee, Danner & Bass's ABBV Position: Q2 2026 in Review

Lee, Danner & Bass reduced its AbbVie (ABBV) stake by 0.46% in Q2 2026, selling an estimated $20.9K and leaving 20,843 shares worth $5.24M. The position accounts for 0.3% of the portfolio, ranked #71.

Lee, Danner & Bass first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. 1,797 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Lee, Danner & Bass held 20,843 shares of AbbVie worth $5.24M as of Q2 2026.
  • Lee, Danner & Bass sold 97 AbbVie shares in Q2 2026, an estimated $20.9K.
  • AbbVie made up 0.3% of Lee, Danner & Bass's portfolio in Q2 2026, its #71 holding.
  • Lee, Danner & Bass first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • 1,797 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Lee, Danner & Bass's 13F filing for Q2 2026, filed 21 Jul 2026.